- Home
- NAUT vs FBIO Comparison
NAUT vs FBIO Comparison
Compare NAUT & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAUT
- FBIO
- Stock Information
- Founded
- NAUT 2016
- FBIO 2006
- Country
- NAUT United States
- FBIO United States
- Employees
- NAUT N/A
- FBIO N/A
- Industry
- NAUT Biotechnology: Laboratory Analytical Instruments
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- NAUT Industrials
- FBIO Health Care
- Exchange
- NAUT Nasdaq
- FBIO Nasdaq
- Market Cap
- NAUT 104.7M
- FBIO 88.7M
- IPO Year
- NAUT N/A
- FBIO N/A
- Fundamental
- Price
- NAUT $1.41
- FBIO $2.54
- Analyst Decision
- NAUT Strong Sell
- FBIO Strong Buy
- Analyst Count
- NAUT 1
- FBIO 2
- Target Price
- NAUT $1.75
- FBIO $16.50
- AVG Volume (30 Days)
- NAUT 613.3K
- FBIO 1.0M
- Earning Date
- NAUT 10-28-2025
- FBIO 11-13-2025
- Dividend Yield
- NAUT N/A
- FBIO N/A
- EPS Growth
- NAUT N/A
- FBIO N/A
- EPS
- NAUT N/A
- FBIO N/A
- Revenue
- NAUT N/A
- FBIO $59,301,000.00
- Revenue This Year
- NAUT N/A
- FBIO $31.85
- Revenue Next Year
- NAUT N/A
- FBIO $44.43
- P/E Ratio
- NAUT N/A
- FBIO N/A
- Revenue Growth
- NAUT N/A
- FBIO N/A
- 52 Week Low
- NAUT $0.62
- FBIO $1.33
- 52 Week High
- NAUT $2.92
- FBIO $4.20
- Technical
- Relative Strength Index (RSI)
- NAUT 63.95
- FBIO 38.92
- Support Level
- NAUT $1.21
- FBIO $2.47
- Resistance Level
- NAUT $1.52
- FBIO $2.61
- Average True Range (ATR)
- NAUT 0.18
- FBIO 0.14
- MACD
- NAUT 0.03
- FBIO -0.04
- Stochastic Oscillator
- NAUT 77.34
- FBIO 20.93
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.